Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome

Figure 7 Somatostatin cell densities (A) and somatostatin immunoreactivity intensities (B) in IBS-total, IBS-D, IBS-M and IBS-D patients. The symbols are the same as in Figures 1 and 4. IBS: Irritable bowel syndrome; IBS-total: All patients with irritable bowel syndrome; IBS-D: Patients with diarrhea as the predominant syndrome; IBS-M: Patients with both diarrhea and constipation; IBS-C: Patients with constipation as the predominant syndrome. ^aP < 0.05, ^bP < 0.01 and ^dP < 0.01 vs controls.